You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

48 search results for: disease control

Assessing EoE: Measuring Quality of Life in Patients With EoE
expert video

Assessing EoE: Measuring Quality of Life in Patients With EoE

Gastroenterology
Join Dr. Nirmala Gonsalves as she reviews some of the tools to assess quality-of-life outcomes in patients with EoE
View more
The Need for Maintenance Therapy in EoE
expert video

The Need for Maintenance Therapy in EoE

Gastroenterology
Hear Dr. Evan Dellon outline the benefits of maintenance therapy in EoE and the importance of an individualized treatment approach for each patient
View more
Assessing EoE: Assessing Symptoms in Patients With EoE
expert video

Assessing EoE: Assessing Symptoms in Patients With EoE

Gastroenterology
Join Dr. Nirmala Gonsalves as she reviews symptoms of EoE and tools to assess symptoms in patients with EoE.
View more
Partnering With Patients: Scores That Matter in CRSwNP
interactivity

Partnering With Patients: Scores That Matter in CRSwNP

Rhinology
Learn how partnering with patients and considering the clinical relevance of symptom improvements can improve patient quality of life
View more
ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma
Podcast

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Pulmonology
Join Professors Klaus Rabe and Ian Pavord as they discuss the importance of on-treatment clinical remission as a goal in asthma management.
View more
ADVENT On Air | Remission in CRSwNP
Podcast

ADVENT On Air | Remission in CRSwNP

Rhinology
Prof. Peter Hellings and Dr. Stella Lee discuss the concept of remission for patients with chronic rhinosinusitis with nasal polyps.
View more
The Pathophysiology of Type 2 Inflammation in CRSwNP
interactivity

The Pathophysiology of Type 2 Inflammation in CRSwNP

Rhinology
Learn how type 2 inflammation underlies the pathophysiology of CRSwNP
View more
IRS-ISIAN 2024 | Emerging Expert Definitions of Remission in CRSwNP
expert video

IRS-ISIAN 2024 | Emerging Expert Definitions of Remission in CRSwNP

Rhinology
Prof. Peter Hellings highlights the EPOS/EUFOREA 2024 definition of remission and calls for an elevation of treatment goals in CRSwNP.
View more
IRS-ISIAN 2024 | Remission in CRSwNP: A Real-World Perspective
expert video

IRS-ISIAN 2024 | Remission in CRSwNP: A Real-World Perspective

Rhinology
Prof. Eugenio De Corso describes the importance of real-world evidence for understanding the prospects of remission and the emerging evidence of biologic effectiveness for patients with CRSwNP.
View more
Can advanced systemic therapies modify pathomechanisms in AD?
expert video

Can advanced systemic therapies modify pathomechanisms in AD?

Dermatology
Dr. Ramien discusses evidence showing that advanced therapies can modify the mechanisms of atopic dermatitis, improving skin barrier function, normalizing the skin microbiome, and reducing chronic itch.
View more
Should we Still Operate on Patients With Chronic Rhinosinusitis With Nasal Polyps?
expert video

Should we Still Operate on Patients With Chronic Rhinosinusitis With Nasal Polyps?

Rhinology
This video clip from the EAACI 2024 symposium discusses whether patients with CRSwNP should undergo a surgery.
View more
IRS-ISIAN 2024 | Targeting Type 2 Inflammation: Managing Smell Loss and Congestion in Patients With Recurrent CRSwNP
expert video

IRS-ISIAN 2024 | Targeting Type 2 Inflammation: Managing Smell Loss and Congestion in Patients With Recurrent CRSwNP

Rhinology
Prof. Joaquim Mullol reports on biologic improvements in sense of smell and nasal congestion in patients with and without a history of endoscopic sinus surgery.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: Dominican RepublicChange country/region